Table 2.
Prevalence of OSMF on the basis of age group
| Age group (in years) | Total | Percentage | Stage | Number | Percentage | Mean±SD |
|---|---|---|---|---|---|---|
| 10-20 years (Group I) | 40 | 4.65% | Stage I | 10 | 25% | 10±0.142 |
| Stage II | 30 | 75% | ||||
| Stage III | 00 | - | ||||
| Stage IV | 00 | - | ||||
| 20-30 years (Group II) | 264 | 30.70% | Stage I | 80 | 30.30% | 66±7.79 |
| Stage II | 90 | 34.09% | ||||
| Stage III | 94 | 35.61% | ||||
| Stage IV | 00 | - | ||||
| 30-40 years (Group III) | 296 | 34.42% | Stage I | 00 | 74±11.25 | |
| Stage II | 162 | 54.73% | ||||
| Stage III | 134 | 45.27% | ||||
| Stage IV | 00 | - | ||||
| 40-50 years (Group IV) | 240 | 27.91% | Stage I | 00 | - | 60±5.23 |
| Stage II | 120 | 50% | ||||
| Stage III | 70 | 29.17% | ||||
| Stage IV | 50 | 20.83% | ||||
| 50-60 years (Group V) | 20 | 2.32% | Stage I | 00 | - | 5±0.11 |
| Stage II | 00 | - | ||||
| Stage III | 00 | - | ||||
| Stage IV | 20 | 100% | ||||
| P<0.05 | 860 |